- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Soft Palate.
Displaying page 1 of 1.
EudraCT Number: 2017-004130-28 | Sponsor Protocol Number: ZMK_201501-ONF | Start Date*: 2018-07-25 | |||||||||||
Sponsor Name:Universitätsklinikum Bonn | |||||||||||||
Full Title: Occurence of Oronasal Fistulas (ONF) using a fibrin sealant patch in primary palatoplasty | |||||||||||||
Medical condition: Cleft lip and palate | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004107-37 | Sponsor Protocol Number: HNBE-03-01 | Start Date*: 2004-11-12 |
Sponsor Name:Genetronics Biomedical Corporation | ||
Full Title: A Randomized Trial Comparing Preservation of Function Status After Either MedPulser® Electroporation with Intraumoral Bleomycin Therapy or Surgery in Patients with Locally Recurrent or Second Prima... | ||
Medical condition: Patients with locally recurrent or second primary SCC of the anterior oral cavity, soft palate, and tonsil that have failed primary curative therapy in whom surgical resection is seen as an option ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-001779-38 | Sponsor Protocol Number: MRZ60201_2069_1 | Start Date*: 2011-11-30 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: Prospective, randomized, double-blind, placebo-controlled, parallel-group, 3-stage dose-finding study to identify a safe and effective dose of NT 201 for unilateral injection into the soft palate f... | |||||||||||||
Medical condition: Habitual snoring | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019952-35 | Sponsor Protocol Number: CS001P3 | Start Date*: 2010-09-14 |
Sponsor Name:CEL-SCI Corporation | ||
Full Title: A Phase III, Open-label, Randomized, Multi-center Study of the Effects of Leukocyte Interleukin, Injection [Multikine] Plus Standard of Care (Surgery + Radiotherapy or Surgery + Concurrent Chemorad... | ||
Medical condition: Subjects with Advanced Primary Sqamous Cell Carcinoma of the oral Cavity/Soft Palate | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) PL (Completed) GB (GB - no longer in EU/EEA) AT (Prematurely Ended) RO (Ongoing) HR (Ongoing) ES (Prematurely Ended) IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002244-16 | Sponsor Protocol Number: NRG-HN002 | Start Date*: 2016-09-12 | |||||||||||
Sponsor Name:Irish Clinical Oncology Research Group CLG, trading as Cancer Trials Ireland | |||||||||||||
Full Title: A Randomized Phase II Trial for Patients with p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer | |||||||||||||
Medical condition: Locoregionally advanced oropharyngeal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015410-22 | Sponsor Protocol Number: AMACE | Start Date*: 2010-04-30 |
Sponsor Name:Medizinische Fakultaet der Technischen Universitaet Muenchen | ||
Full Title: A multicenter, randomized, double-blind study with 2 groups as prove of concept for the treatment of ACE induced angioedema with subcutaneous Icatibant | ||
Medical condition: The study objective is to assess the efficacy and safety of the Bradykinin-2 (BK-2) receptor antagonist Icatibant compared to a historic group of 47 patients with ACE inhibitor induced angioedema w... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006340-60 | Sponsor Protocol Number: OPTUK RFCP PRO002.04 | Start Date*: 2007-03-14 |
Sponsor Name:OptiNose UK Ltd | ||
Full Title: A Double Blind, Randomised, Parallel Group, Placebo-Controlled Study to Investigate the Efficacy and Tolerability of Intranasal Fluticasone Propionate Delivered by the Optinose Device in Adult Pati... | ||
Medical condition: treatment of bilateral nasal polyposis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: CZ (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002414-12 | Sponsor Protocol Number: 12082.101 | Start Date*: Information not available in EudraCT |
Sponsor Name:PARI Pharma GmbH | ||
Full Title: A randomised, open, controlled pilot study to investigate the efficacy and safety of Buparid/PARI SINUS versus Budes® Nasal Spray in the therapy of Chronic Rhinosinusitis (CRS) with polyposis nasi ... | ||
Medical condition: Chronic Rhinosinusitis (CRS) with polyposis nasi | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002745-38 | Sponsor Protocol Number: GTI-4419-202 | Start Date*: 2020-01-16 | |||||||||||
Sponsor Name:Galera Therapeutics, Inc. | |||||||||||||
Full Title: An Open Label Multi-Center Study of the Effects of Superoxide Dismutase Mimetic GC4419 when Administered to Reduce the Incidence and Severity of Severe Oral Mucositis (SOM) Associated with Chemorad... | |||||||||||||
Medical condition: Severe Oral Mucositis (SOM) Associated with Chemoradiotherapy for Locally Advanced, Non-Metastatic Head and Neck Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) PL (Completed) BE (Completed) CZ (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003702-41 | Sponsor Protocol Number: IDR-OM-02 | Start Date*: 2018-07-03 |
Sponsor Name:Soligenix UK Limited | ||
Full Title: A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated With Concomitant Chemoradiation for... | ||
Medical condition: Oral Mucositis in Patients Being Treated with Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) BE (Completed) FR (Ongoing) ES (Completed) HU (Completed) PL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-005991-41 | Sponsor Protocol Number: OPTUK MSPP PRO002 | Start Date*: 2007-03-12 | |||||||||||
Sponsor Name:OptiNose UK Ltd. | |||||||||||||
Full Title: A multicentre, double-blind, placebo-controlled evaluation of intranasal sumatriptan delivered with the OptiNose powder device in the treatment of acute migraine. | |||||||||||||
Medical condition: Acute Treatment of Migraine with or without Aura | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001670-28 | Sponsor Protocol Number: BER-1272-0058-I | Start Date*: 2013-03-18 | |||||||||||
Sponsor Name:Medizinische Fakultät der Technischen Universität München | |||||||||||||
Full Title: Angiotensin Converting Enzyme Inhibitor (ACE) Induced Angioedema BERINERT Randomized, double-blind, two arms, multicenter, Phase III study of Berinert for treatment of ACE induced Angioedema | |||||||||||||
Medical condition: Angiotensin – Converting – Enzyme – Inhibitors (ACEi) are used in the treatment of several types of cardiovascular and renal diseases. A known side effect of ACEi are angioedema of the head and ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014870-16 | Sponsor Protocol Number: BA2009-28-01 | Start Date*: 2009-12-10 |
Sponsor Name:BioAlliance Pharma | ||
Full Title: A phase II, multicentre, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of Clonidine Lauriad® 50 μg and 100 μg mucoadhesive buccal tablet (MBT) applied once da... | ||
Medical condition: Prevention and treatment of chemoradion therapy-induced oral mucositis. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) ES (Completed) DE (Completed) HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-002669-40 | Sponsor Protocol Number: ALD518-CLIN-009 | Start Date*: 2011-12-15 | |||||||||||
Sponsor Name:Alder BioPharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of ALD518 in the Reduction of Oral Mucositis in Subjects With Head and Ne... | |||||||||||||
Medical condition: Oral Mucositis in subjects with head and neck cancer receiving concomitant chemotherapy and radiotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) AT (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.